| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | Three Months Ended September 30, | | Nine Months Ended September 30, |
| Financial statement caption | | 2025 | | 2024 | | 2025 | | 2024 |
| Non-Designated Derivative Instruments | | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| Unrealized (gains) losses | Other (income) expense, net | | $ | — | | | $ | (7) | | | $ | 2 | | | $ | 40 | |
| Designated Derivative Instruments | | | | | | | | | |
| Realized (gains) losses | Interest and debt (income) expense | | $ | (8,730) | | | $ | (13,848) | | | $ | (24,807) | | | $ | (42,826) | |
| Unrealized (gains) losses | Comprehensive (income) loss | | $ | 1,466 | | | $ | 41,320 | | | $ | 26,683 | | | $ | (10,391) | |
| | | | | | | | | |
| | | | | | | | | |
